Understanding how the cells become malignants: Hope for better cancer treatments
Despite the significant improvement in survival rates for many types of cancer, this disease remains a major cause of death and health burden in Canada. Efforts in biomedical research contribute daily to the identification of the factors that cause cancer and the defects in genes that protect against the development of this disease, thus facilitating the establishment of novel diagnostic tools and treatment options.
Algorithme Pharma Gains Key Patient Access Through Partnership with Hôpital Maisonneuve-Rosemont (HMR)
Algorithme Pharma, a leading early stage clinical research organization, is pleased to offer sponsors increased patient access in key therapeutic areas through the strategic partnership with Hôpital Maisonneuve-Rosemont (HMR).